ClinicalTrials.gg
Sign In

Gliosarcoma clinical trials

The registry lists 488 studies for Gliosarcoma across more than 10 countries. 14 are recruiting or about to start. 17 of them are mainly about Gliosarcoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Gliosarcoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
343
Terminated
70
Active, not recruiting
20
Status unknown
20
Withdrawn
19
Recruiting
12

Phase

Phase 2
261
Phase 1
248
Phase 3
21
Early Phase 1
8

Where

United States
430
Canada
30
United Kingdom
16
Switzerland
16
France
13
Netherlands
13

Who runs them

National Cancer Institute (NCI) (95) · Duke University (37) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (34) · M.D. Anderson Cancer Center (22) · Jonsson Comprehensive Cancer Center (15) · European Organisation for Research and Treatment of Cancer - EORTC (13) · City of Hope Medical Center (11) · Memorial Sloan Kettering Cancer Center (10)

What is being tested here

Drugs under test in Gliosarcoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Temozolomide2596
ERAS-801202
Ipilimumab114
G 207103
Oncolytic HSV-1 G207103
IL-12-expressing HSV-1 NSC 733972102
Tasadenoturev102
Cemiplimab101
Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102101
Abexinostat101

Drug classes tested here Alkylating agents 2 open · Tyrosine kinase inhibitors (TKIs) 2 open · Immune checkpoint inhibitors 2 open · HDAC inhibitors 1 open · Angiogenesis inhibitors 35

Coming up

2phase 3 studies under way
12studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 12 Gliosarcoma studies recruiting now, 11 (92%) set no upper age limit and 1 (8%) stop at 75 or younger. 2 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (8%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
101 (8%)1 (8%)
1811 (92%)11 (92%)
3011 (92%)11 (92%)
4011 (92%)11 (92%)
5011 (92%)11 (92%)
6511 (92%)11 (92%)
7511 (92%)11 (92%)
8511 (92%)11 (92%)

Across all 488 studies, recruiting or not: 9% stop at 75 or younger and 6% at 65; 9% take children; 0% are for women only and 1% for men only; <1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gliosarcoma studies take

Of 54 phase 1 interventional studies under Gliosarcoma, half reached primary completion within 59 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 159 mo36–106 · 54 studies—53 mo35–90 · 48 studies
Phase 1/268 mo53–82 · 24 studies——
Phase 249 mo32–69 · 43 studies—49 mo32–71 · 42 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 488. Browse all 488 → or search them.

Gliosarcoma clinical trials — 488 studies | ClinicalTrials.gg